Alexander Blair, CLO, CSO, and Corporate Secretary of AEON Biopharma, Inc., filed a Form 4 on November 20, 2026, disclosing an open-market purchase of Class A Common Stock in the issuer on that same date.
Key Highlights
- Reporting person: Wilson Alexander Blair, identified as CLO, CSO and Corp Secretary of AEON Biopharma, Inc.
- Transaction: Purchase (Code P) of 135,706 shares of Class A Common Stock on November 20, 2026.
- Weighted average price: $0.1288 per share, with individual transactions ranging from $0.1235 to $0.1300 per share, inclusive.
- Beneficial ownership following transaction: 2,318,711 shares held directly.
- No derivative securities were reported as acquired, disposed of, or beneficially owned in Table II.
Blair's November 2026 Open-Market Purchase of AEON Biopharma Class A Shares
According to the filing, Wilson Alexander Blair, serving as CLO, CSO and Corp Secretary at AEON Biopharma, Inc. (NASDAQ:AEON), acquired 135,706 shares of Class A Common Stock on November 20, 2026, at a weighted average price of $0.1288 per share. The filing notes that the shares were purchased across multiple transactions at prices ranging from $0.1235 to $0.1300 per share, inclusive.
As disclosed in the filing's footnote, Blair "undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote." Following the reported transaction, Blair directly holds 2,318,711 shares of Class A Common Stock, according to the filing.
The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as the corresponding checkbox was not marked. No derivative securities were reported in Table II of the form. The form was filed as a single-reporting-person filing, signed by Alexander Wilson on November 20, 2026.
What Was Disclosed
AEON Biopharma officer Wilson Alexander Blair reported a purchase of 135,706 shares of Class A Common Stock at a weighted average price of $0.1288 on November 20, 2026, bringing his total direct beneficial ownership to 2,318,711 shares.




Please wait processing your request...